- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03986060
Shouldice Hospital Outcome Study
June 7, 2022 updated by: Joel Katz, York University
A prospective cohort study recruiting participants from the Shouldice Hospital.
The study population consists of healthy patients electing to receive hernia surgery for a primary inguinal hernia on an inpatient basis.
The goal of this study is to determine the incidence of hernia pain and its intensity as well as other related outcomes up to one year after primary unilateral inguinal hernia repair.
Study Overview
Status
Recruiting
Conditions
Study Type
Observational
Enrollment (Anticipated)
3000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Joel Katz, PhD
- Phone Number: 9999999999
- Email: jkatz@yorku.ca
Study Contact Backup
- Name: Marguerite Mainprize
- Phone Number: 297 905 889 1125
- Email: research@shouldice.com
Study Locations
-
-
Ontario
-
Thornhill, Ontario, Canada, L3T4A3
- Recruiting
- Shouldice hospital
-
Contact:
- Marguerite Mainprize, MSc
- Phone Number: 297 905 889 1125
- Email: mmainprize@shouldice.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
The population under study comprises patients recruited from Shouldice Hospital undergoing inguinal hernia repair.
We aim to recruit a sample size of 3,000 patients, males and females, ages 18-90 years, all nationalities and races, capable of speaking and reading English, in good general health, there is no geographic location constraint.
Description
Inclusion Criteria:
- Provide signed and dated informed consent form.
- Willing to comply with all study procedures and be available for the duration of the study (patients have fixed address, access to phone, email, internet, and/or a computer)
- Male or female, aged 18 to 90 years.
- Subjects having surgery on a primary unilateral inguinal hernia
- In good general health as evidenced by medical history
- Capable of speaking and reading English sufficiently well to complete the questionnaires
Exclusion Criteria:
- Surgery is deemed an emergency procedure (any obstruction, incarceration or irreducible hernias).
- Other abdominal hernias being operated on at the same time or surgery is planned during the follow-up period (incisional and umbilical hernias)
- If hernia recurs within the study period and there is a reoperation within the year
- BMI >40kg/m2
- Patients unable to understand English, written and spoken
- Patients with collagen or connective tissue disorders
- Local (site of surgery) or systemic infection
- Any known diseases that impair nerve function
- Patients who end up getting a mesh repair during surgery
- Impairment of cognitive function (e.g. dementia)
- Pregnancy or lactation
- Anything that would place the individual at increased risk or preclude the individual's full compliance with or completion of the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Proportion of participants with pain severity scores > zero at one year
Time Frame: one-year post surgery
|
Brief Pain Inventory - pain severity 0-10 numeric rating scale.
Typically score >= 4 corresponds to moderate-to severe pain severity
|
one-year post surgery
|
Proportion of participants with pain-related interference in multiple life domains
Time Frame: one-year post surgery
|
Brief Pain Inventory - pain interference
|
one-year post surgery
|
Proportion of participants with neuropathic pain symptoms
Time Frame: one year
|
ID Pain 6-items total score ranges from 0 to 6
|
one year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
proportion of participants with significant symptoms of anxiety, depression
Time Frame: one-year post surgery
|
Patient Health Questionnaire for Depression and Anxiety - PHQ-4 total score range from 0-12; anxiety subscale 0-6; depression subscale 0-6.
total score cutoffs: 0-2 normal; 3-5 mild; 6-8 moderate; 9-12 severe
|
one-year post surgery
|
Do preoperative perceived stress scores predict pain incidence, severity, and/or interference
Time Frame: one-year
|
Stress Assessment Test - no norms at present.
Scale developed by authors and being validated.
|
one-year
|
Does pre-operative resilience scores predict lower pain incidence, severity, and/or interference
Time Frame: one-year
|
Connor-Davidson Resilience Scale-2.
Total score ranges from 0-8.
There are no clinical cut-offs for this scale
|
one-year
|
Do pain preoperative and early postoperative pain catastrophizing scores predict pain incidence, severity, and/or interference
Time Frame: one year
|
Pain Catastrophizing Scale -4 item.
Total score range: 0-16.
There are no sub scales and no cut-offs for this scale
|
one year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Joel Katz, PhD, York University
- Principal Investigator: Robert BenDavid, MD, Shouldice hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 17, 2019
Primary Completion (Anticipated)
May 2, 2023
Study Completion (Anticipated)
May 2, 2024
Study Registration Dates
First Submitted
June 12, 2019
First Submitted That Met QC Criteria
June 12, 2019
First Posted (Actual)
June 14, 2019
Study Record Updates
Last Update Posted (Actual)
June 8, 2022
Last Update Submitted That Met QC Criteria
June 7, 2022
Last Verified
June 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Inguinal Hernia
-
Children's Mercy Hospital Kansas CityRecruitingInguinal Hernia | Inguinal Hernia, Indirect | Inguinal Hernia Unilateral | Inguinal Hernia BilateralUnited States
-
Hospital General Universitario ElcheCompletedInguinal Hernia | Inguinal Hernia Repair | Open Inguinal Hernia
-
San Bonifacio HospitalCompletedIndirect Inguinal Hernia | Direct Inguinal HerniaItaly
-
Bakirkoy Dr. Sadi Konuk Research and Training HospitalEnrolling by invitationInguinal Hernia | Strangulated Inguinal Hernia | Incarcerated Inguinal HerniaTurkey
-
University Hospital, GhentMedriCompleted
-
Ahmadullah DanishCompletedIncarcerated Inguinal HerniaAfghanistan
-
General Hospital of LarissaUnknown
-
Alexandria UniversityCompletedBilateral Inguinal Hernia
-
Hospital Siberia-SerenaUnknownPrimary Inguinal HerniaSpain
-
Diskapi Teaching and Research HospitalCompleted